Elanco wins conditional EU antitrust okay for $7.6 bln Bayer deal

Elanco Animal Health secured EU antitrust clearance on Monday to buy Bayer's veterinary drugs unit after pledging to sell some products to address competition concerns about the $7.6 billion deal.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.